New FDA Approval - Epclusa

Drug

sofosbuvir / velpatasvir [Epclusa]

Indication

Epclusa is used for treatment of chronic hepatitis C (HCV). It can be used in patients both with and without cirrhosis. If the patient does have cirrhosis (moderate to severe), Epclusa should be given with ribavirin.

Eplcusa can be given all by its lonesome self if there is no cirrhosis or if cirrhosis is in earlier stages.

FDA Approval, Clinical, PracticeBrandon DysonJuly 8, 2016Hepatitis C, Harvoni, HCV, HepC, sofosbuvir, velpatasvir, epclusa, FDA approval, new drug, cirrhosis